Skip to main content

Peer Review reports

From: Severe hematuria in a patient receiving bevacizumab and pembrolizumab for metastatic cervical cancer: a case report

Original Submission
20 Apr 2022 Submitted Original manuscript
29 Apr 2022 Reviewed Reviewer Report
6 May 2022 Reviewed Reviewer Report - Tony Lopez
6 Jun 2022 Author responded Author comments - Yanxin Liu
Resubmission - Version 2
6 Jun 2022 Submitted Manuscript version 2
29 Jun 2022 Reviewed Reviewer Report
2 Sep 2022 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
17 Feb 2023 Editorially accepted
10 Mar 2023 Article published 10.1186/s12882-023-03101-9

You can find further information about peer review here.

Back to article page